Search

Chinese
Resource Library / IV Infusion

case-study

IV Infusion

Sponsor worked with Frontage on BE/BA study using IV infusion. The product was approved in tablet form however the sponsor was looking to convert the drug into an injectable liquid as a quick on set for the treatment of severe migraines.

Register to gain access to gated resources.

"*" indicates required fields

Country
Please only hit the submit button once.
I AGREE*
This field is for validation purposes and should be left unchanged.

Resources to Consider

Left arrow
Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays​
poster

Quantitative Assessment of mRNA Drug Biological Activity by...
Biological activity of mRNA drugs, historically assessed via animal study, is critical to ...
Access Resource
A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
poster

A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication...
Lentiviral vectors are widely used in gene and cell therapy for diseases like HIV, cancer,...
Access Resource
Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase LC-MS.MS
poster

Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase...
Oligonucleotides (OGNs) have attracted massive attention as therapeutics due to their abil...
Access Resource
Quantitative Analysis of Antibody Conjugate Payload by LC MS/MS without Immunocapture
poster

Quantitative Analysis of Antibody Conjugate Payload by LC MS/MS...
Quantitative analysis of ADC free and conjugated payload and its metabolites is critical t...
Access Resource
Genotoxic Potential of an Antiviral Pyrimidine Nucleoside Analogue, 5-(2-chloroethyl)-2′-deoxyuridine (CEDU)
poster

Genotoxic Potential of an Antiviral Pyrimidine Nucleoside Analogue,...
5-(2-Chloroethyl)-2'-deoxyuridine (CEDU) is a nucleoside analogue developed as an antivira...
Access Resource
Cost Effective and Efficient Progression of Lead Drug Candidates to First in Human Studies
webinar

Cost Effective and Efficient Progression of Lead Drug Candidates to...
Hosted by ISSX, Frontage's own Dr John Kapeghian discusses the "Cost Effective and Efficie...
Access Resource
Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids
poster

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug...
This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and...
Access Resource
A Competitive Ligand-binding Assay for the Detection of Neutralizing Antibodies Against XTMAB-16
poster

A Competitive Ligand-binding Assay for the Detection of Neutralizing...
Frontage develops a full validation of the XTMAB-16 NAb (neutralizing antibody) assay with...
Access Resource
Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes
poster

Validation of a 384 gene hybridization capture-based pharmacogenomics...
​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly deter...
Access Resource
Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation of NF-L and GFAP
poster

Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation...
In this poster, we validate ultra-high sensitive SIMOA assays for the successful quantitat...
Access Resource
Quantitative Whole-Body Autoradiography (QWBA) and Radiation Dosimetry​
webinar

Quantitative Whole-Body Autoradiography (QWBA) and Radiation...
This webinar gives an overview of QWBA and hAME study services, an understanding of the gu...
Access Resource
GeneTox: A Pivotal Part of Safety Assessment
webinar

GeneTox: A Pivotal Part of Safety Assessment
Genotoxicity testing is the basic requirement for the regulatory submission of drug candid...
Access Resource
Right arrow